Celsion Earnings Down $CLSN $XHS

Celsion Corporation an oncology drug firm, has announced its financial results for the first quarter of FY-2015. The results shows, revenues remains stable at $1.25 Million whereas EPS went down from -$0.33 to -$0.35 YoY. View the full earnings release here.